News Opyl Limited

Equities

Delayed Australian S.E. Other stock markets 12:01:18 2024-06-11 am EDT			5-day change	1st Jan Change
0.024 ^AUD	-7.69%		+26.32%	-14.29%

Jun. 06	Opyl Secures First TrialGen Contract with Brain Vector	MT
Apr. 29	Opyl Expands TrialKey Coverage; Shares Up 38%	MT

Opyl Secures First TrialGen Contract with Brain Vector	Jun. 05	MT
Opyl Expands TrialKey Coverage; Shares Up 38%	Apr. 28	MT
Opyl to Divest Opin Business	Apr. 22	MT
Opyl Receives Offer for Patient Recruitment Business	Mar. 22	MT
Trial Screen Pty Ltd entered into a non-binding offer to acquire Opin business from Opyl Limited.	Mar. 21	CI
Opyl Requests Trading Halt After Receiving Offer For Opin Business	Mar. 20	MT
Opyl Chair Stepping Down in End-April	Mar. 15	MT
Opyl Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Opyl Raises Nearly AU$900,000 from Rights Issue Shortfall Placement	Feb. 09	MT
Opyl Grows Cash Receipts for Fiscal Q2	Jan. 31	MT
Opyl Receives Commitments for Potential Shortfall	Jan. 02	MT
Rights Issue: 2 new shares @ 0.03 AUD for 5 existing shares	Dec. 17	FA
Opyl Appoints Interim CEO	Nov. 23	MT
Opyl Limited Appoints Saurabh Jain as Interim Chief Executive Officer	Nov. 23	CI
Opyl Secures R&D Tax Rebate for Fiscal Year 2023	23-09-22	MT
Opyl Limited Announces Appointment of Antanas Guoga as Director, Effective from September 4, 2023	23-09-05	CI
Opyl Limited Announces Board Update	23-09-03	CI
Opyl Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Opyl Limited Launches TrialKey MVP	23-08-23	CI
Opyl Limited Announces Senior Leadership Changes	23-07-05	CI

No results for this search